Nicotinamide Riboside (NR-CL)

Nicotinamide riboside (NR) is a form of vitamin B3 that the body converts directly into NAD+, a coenzyme every cell needs for energy production, DNA repair, and activating longevity-related sirtuin enzymes. Because NAD+ levels can fall by as much as 50% by middle age, NR supplementation, particularly as NR-CL (nicotinamide riboside chloride), is used in clinical research to help restore them. NR-CL is the most stable, bioavailable salt form and the most extensively studied in human trials.

Quick Facts

• Category: Vitamin B3 derivative / NAD+ precursor
• Also known as: NR, Niagen®, NR Chloride, NR-CL, Nicotinamide Riboside Chloride
• Most-studied form: NR-CL (Nicotinamide Riboside Chloride), the most stable, bioavailable salt form
• Key benefit: Restores declining NAD+ levels to support cellular energy, DNA repair, and healthy aging
• Bioavailability rating: High: enters cells directly without requiring phosphorylation

What Is Nicotinamide Riboside?

Nicotinamide riboside (NR) is a naturally occurring form of vitamin B3, the same vitamin family as niacin and niacinamide, and one of the most efficient known precursors to NAD+ (Nicotinamide Adenine Dinucleotide). NAD+ is a coenzyme present in every cell of the human body and is essential for life itself: without adequate NAD+, cells cannot produce energy, repair DNA, or regulate the metabolic processes that keep the body functioning.

NAD+ levels fall sharply with age (by as much as 50% by middle age), a decline researchers have directly linked to the metabolic dysfunction, cognitive decline, and reduced resilience that characterize aging.

NR was first identified as a distinct compound in the early 2000s, when researcher Charles Brenner discovered it as a novel NAD+ precursor in yeast. It gained significant attention after a landmark 2013 study by Hongbo Zhang and Johan Auwerx at EPFL demonstrated that NR supplementation could reverse mitochondrial decline and extend healthy lifespan in mice. Since then, NR has become one of the most rigorously studied longevity supplements in human clinical trials.

Natural food sources of NR include cow's milk (~0.5–3.9 μmol/L), yeast, certain vegetables, and fermented foods, but dietary amounts are negligible compared to what research suggests is needed to meaningfully raise NAD+ levels. Supplementation is therefore the only practical way to reach therapeutic concentrations. NR is classified as a form of vitamin B3 and has received GRAS (Generally Recognized As Safe) status from the U.S. Food and Drug Administration.

Forms & Bioavailability: Why NR-CL Is the Right Choice

NR-CL is generally considered the strongest practical choice among NAD+ precursors because it combines the same high bioavailability as free NR with better chemical stability during storage and manufacturing. Not all NAD+ precursors are equal, and understanding the differences matters when evaluating any supplement that claims to boost NAD+.

The NR vs. NMN Debate

Both NR and NMN ultimately raise NAD+ levels, but they take slightly different routes to get there:

• NR enters cells directly via nucleoside transporters and is converted to NMN inside the cell by NR kinase enzymes (NRK1 and NRK2), then to NAD+ by NMNAT enzymes, a clear, well-characterized uptake pathway.
• NMN, being a larger molecule with an extra phosphate group, cannot directly enter most cell types and must first be dephosphorylated to NR in the gut or blood before entering cells, essentially becoming NR anyway. The notable exception is intestinal cells, which have a direct NMN transporter (Slc12a8).
• A 2022 study in Science Advances confirmed that most orally consumed NR and NMN undergo gut microbiota-mediated conversion before reaching systemic circulation, suggesting ultimate bioavailability depends significantly on individual gut microbiome composition.

The human clinical evidence base currently favors NR, simply because the majority of human bioavailability and efficacy trials have been conducted on NR rather than NMN, meaning NR has more published, peer-reviewed human trials confirming it safely and reliably raises blood NAD+ levels.

Why NR-CL Specifically?

The chloride salt form of NR offers improved chemical stability during storage and manufacturing compared to free NR, without any difference in biological activity once absorbed. This makes NR-CL the preferred form for supplement manufacturers prioritizing quality and consistency.

Mechanisms of Action: What NR Does in the Body

NR works primarily by restoring NAD+, the coenzyme that powers cellular energy production, activates longevity-linked sirtuin enzymes, fuels DNA repair, and regulates mitochondrial health. Understanding what NAD+ actually does in the body explains why researchers are so focused on NR as a way to replenish it.

Fueling the Energy Production Chain

NAD+ is the central electron carrier in cellular metabolism. It accepts electrons during glycolysis, the citric acid (TCA) cycle, and beta-oxidation of fatty acids, passing them to the mitochondrial electron transport chain to generate ATP, the energy currency cells run on. Without sufficient NAD+, this chain slows down: mitochondria become less efficient, cells produce less energy, and the cumulative effect is the fatigue and metabolic decline associated with aging.

Activating Sirtuins: The Longevity Enzymes

Sirtuins (SIRT1–SIRT7) are a family of NAD+-dependent enzymes often called "longevity regulators." They act as master metabolic switches controlling gene expression, inflammation, mitochondrial function, stress resilience, DNA repair coordination, and circadian rhythm regulation. Critically, sirtuins only function when NAD+ is available: they consume it as a co-substrate in every reaction they catalyze.

As NAD+ declines with age, sirtuin activity falls in parallel, and reduced sirtuin activity has been directly associated with accelerated aging phenotypes in animal models. Restoring NAD+ via NR reactivates sirtuin function: NR has been shown specifically to activate SIRT1 (metabolism and stress response) and SIRT3 (mitochondrial function), and to induce PGC-1α, a master regulator of mitochondrial biogenesis.

Supporting DNA Repair via PARP Enzymes

PARP enzymes (Poly ADP-Ribose Polymerases), particularly PARP1, are the body's frontline DNA damage response system. When DNA strand breaks occur, caused by UV radiation, oxidative stress, or normal cellular errors, PARP1 activates and consumes large quantities of NAD+ to orchestrate repair.

This creates a problematic feedback loop in aging: as DNA damage accumulates, PARP1 activation increases, depleting NAD+ further, which in turn reduces sirtuin activity and mitochondrial function. NR supplementation helps break this cycle by replenishing the NAD+ pool that both PARP and sirtuin systems draw from.

Reducing Neuroinflammation via CD38 Regulation

CD38 is an NAD+-consuming enzyme that increases significantly with age and chronic inflammation, becoming a major driver of age-related NAD+ decline. Research suggests that compounds such as apigenin can inhibit CD38, working synergistically with NR supplementation to preserve NAD+ levels.

Mitochondrial Biogenesis

NR supplementation has been shown to stimulate the creation of new mitochondria through activation of SIRT1 and PGC-1α. In aged skeletal muscle, where mitochondrial dysfunction is a central feature of weakness and fatigue, NR has demonstrated the ability to partially restore the mitochondrial transcriptomic signature toward a younger profile.

Evidence-Based Benefits

Across human clinical trials, the strongest evidence shows NR reliably raises blood and brain NAD+ levels and supports skeletal muscle mitochondrial function, with promising early results for cardiovascular performance, cognitive health, and inflammation.

Reliably Raises Blood NAD+ Levels

Evidence level: Established. The most consistent and well-replicated finding across human trials is that oral NR supplementation significantly raises NAD+ concentrations in blood. Multiple randomized controlled trials have confirmed this, including studies by Trammell et al. (2016), Martens et al. (2018), and Airhart et al. (2017). The increase is typically dose-dependent and seen within days of supplementation.

A 2024 study published in PMC specifically measured NAD+ in the human brain using 31P MRS spectroscopy, finding that NR supplementation increased mean brain NAD+ concentration significantly compared to baseline (0.458 ± 0.053 vs 0.392 ± 0.058 mM; p<0.001), a landmark finding since brain NAD+ had previously only been measurable in animal models.

Skeletal Muscle Function and Mitochondrial Restoration

Evidence level: Established. A pivotal 2020 study published in Cell Reports found that NR supplementation in aged men and women (65+) augmented the skeletal muscle NAD+ metabolome, induced anti-inflammatory transcriptomic signatures, and partially reversed the muscle mitochondrial decline associated with aging. Participants taking 1,000mg NR daily for 21 days showed meaningful changes in muscle gene expression patterns, including genes related to mitochondrial function and inflammation, compared to placebo.

Cardiovascular and Physical Performance

Evidence level: Promising. The NICE trial (2024), published in Nature Communications, was a randomized clinical trial assessing NR (with and without resveratrol) in patients with peripheral artery disease. NR supplementation meaningfully improved 6-minute walk performance compared to placebo. Adding resveratrol did not confer additional benefit over NR alone in this specific context, suggesting NR was the primary driver.

Earlier research (Martens et al., 2018) in healthy middle-aged adults showed that NR at 500mg/day for 6 weeks reduced aortic stiffness and systolic blood pressure in participants with elevated baseline blood pressure, suggesting cardiometabolic benefits beyond simple NAD+ elevation.

Cognitive Health and Neuroprotection

Evidence level: Promising. A 2023 RCT published in PMC assessed NR in older adults with mild cognitive impairment. While NR significantly increased blood NAD+ levels and was well tolerated, cognitive improvements did not reach statistical significance in this trial. A 2025 study in eClinicalMedicine (The Lancet), the first RCT of NR in long-COVID patients, found that 2,000mg/day of NR for 20 weeks was associated with improvements in cognitive symptoms and overall recovery scores compared to placebo. Brain NAD+ restoration appears promising for neurological applications, though larger and longer trials are needed.

Safety at High Doses, Including Neurological Conditions

Evidence level: Established. The NR-SAFE trial (2023), published in Nature Communications, assessed NR at 3,000mg/day in Parkinson's disease patients for 30 days. Oral NR was safe, well-tolerated, and produced a pronounced, systemic augmentation of the NAD+ metabolome even at this very high dose, with no serious adverse events attributed to NR.

Metabolic Health

Evidence level: Emerging. Animal studies have consistently shown that NR prevents high-fat diet-induced obesity, improves insulin sensitivity, and supports healthy glucose metabolism. Human evidence is more limited, with some studies showing modest improvements in liver fat and insulin sensitivity markers, particularly in overweight populations. This remains an active area of research.

Anti-Inflammatory Effects

Evidence level: Promising. Multiple NR trials have reported reductions in inflammatory markers, including circulating cytokines. The mechanism is logical: as NAD+ is restored, sirtuin activity increases, and sirtuins are potent negative regulators of NF-κB, the master inflammatory transcription factor. NR in aged muscle tissue specifically induced anti-inflammatory transcriptomic signatures in the 2020 Cell Reports study.

Dosage & Timing

The dose best supported by human evidence for daily NAD+ maintenance is 250 to 300mg of NR per day, aligned with the doses used in the Martens cardiovascular study and the standard Trammell et al. pharmacokinetic protocols.

Best time to take: Morning, ideally with or shortly after a light meal. NAD+ is involved in circadian rhythm regulation, and there is evidence that NAD+ biosynthesis follows a circadian pattern, with morning supplementation best aligning with this natural rhythm.

Consistency matters more than timing: the NAD+-raising effects of NR are cumulative and require consistent daily use. Most studies show peak blood NAD+ increases at 2–4 weeks of consistent supplementation.

How to Maximize Absorption

NR absorption can be supported by taking it with a small meal, pairing it with a bioavailability enhancer like piperine, avoiding high-dose niacinamide at the same time, keeping to a consistent morning schedule, and staying well hydrated.

• Take with a small meal: NR absorption is not significantly impaired by food, but a small meal can reduce any potential GI sensitivity, particularly at higher doses.

• Piperine (Black Pepper Extract): Piperine, the primary bioactive compound in black pepper extract, is a well-established bioavailability enhancer often studied alongside NR. It inhibits intestinal enzymes and efflux transporters that can reduce absorption of various compounds, and may slow NR's first-pass metabolism, increasing effective absorption.
• Avoid co-administration with high-dose niacinamide: Niacinamide (the amide form of B3) and NR share the same salvage pathway and compete for the same enzymes. Taking very high doses of niacinamide alongside NR may reduce NR's conversion efficiency.

• Morning timing for circadian alignment: Circadian-aligned dosing appears to be favorable based on the biology of NAD+ synthesis.
• Consistent hydration: Adequate hydration supports overall cellular metabolism and the enzymatic pathways involved in NAD+ biosynthesis.

Synergies: What NR Works Best With

NR is often studied and used alongside complementary mitochondrial and sirtuin-support compounds, each targeting a different part of the NAD+ and mitochondrial health pathway.

Trans-Resveratrol

The most discussed NR synergy. Resveratrol is proposed to activate SIRT1, the primary NAD+-dependent sirtuin, by acting as an allosteric activator, essentially lowering the threshold at which SIRT1 responds to NAD+. The theory: NR raises the NAD+ pool, and resveratrol amplifies SIRT1's sensitivity to it. While some controversy exists around resveratrol's direct SIRT1 activation mechanism in vitro, the NICE trial (2024) confirmed NR with resveratrol is well-tolerated, and animal studies have shown combined supplementation raises NAD+ in cardiac and muscle tissue by ~1.6–1.7x more than NR alone.

Pterostilbene

Structurally similar to resveratrol but with superior bioavailability (~80% vs ~20% for resveratrol). Pterostilbene is more lipophilic, allowing better cellular membrane penetration and a longer plasma half-life. It shares the proposed sirtuin-activating mechanism and functions as a potent antioxidant, protecting mitochondria from the oxidative stress that accelerates NAD+ consumption.

Ubiquinol/CoQ10

NAD+ and CoQ10 are both essential components of the mitochondrial electron transport chain, working at adjacent points in the energy production process. NR supports NAD+ levels at Complex I; CoQ10 (as Ubiquinol) shuttles electrons between Complexes I/II and Complex III. Combining them targets mitochondrial energy production from two complementary angles, particularly relevant as both CoQ10 and NAD+ decline with age.

Fisetin

A flavonoid with emerging senolytic properties (selectively clearing senescent "zombie" cells that drive chronic inflammation). Senescent cells are major consumers of NAD+ via PARP activation triggered by their ongoing DNA damage. By reducing senescent cell burden, fisetin may indirectly preserve the NAD+ pool, working synergistically with NR's replenishment strategy.

Urolithin A

Urolithin A activates mitophagy, the cellular process of clearing dysfunctional mitochondria. This is directly complementary to NR: NR stimulates the creation of new mitochondria (biogenesis via PGC-1α), while Urolithin A clears the old, damaged ones. Together, they support mitochondrial quality control from both ends.

Magnesium Bisglycinate

Magnesium is an essential cofactor for over 300 enzymatic reactions, including several involved in NAD+ biosynthesis and ATP production. Magnesium deficiency, extremely common in the general population, directly impairs the enzymatic conversion of NR to NAD+. Correcting a magnesium deficiency, particularly with a highly bioavailable chelated form like magnesium bisglycinate, helps ensure the enzymatic machinery for NAD+ synthesis is properly supported.

Interactions & Contraindications

NR has no confirmed negative drug interactions in current clinical trial data, but caution and medical consultation are advised for people undergoing chemotherapy, taking blood thinners, or with heavy alcohol use.

• Chemotherapy agents: There is a theoretical concern that boosting NAD+, which supports DNA repair and cell survival, could potentially reduce the efficacy of certain chemotherapy drugs that work by inducing DNA damage. This has not been demonstrated in human clinical trials, but until more data exists, cancer patients receiving chemotherapy should discuss NR use with their oncologist.

• Anticoagulants (blood thinners): High-dose B3 derivatives have historically been flagged with anticoagulants. No direct interaction has been confirmed for NR specifically, but caution is warranted.

• Alcohol: Chronic heavy alcohol consumption depletes NAD+ significantly and disrupts the same metabolic pathways NR supports. NR may be beneficial in this context, but alcohol also stresses the liver, which processes both NAD+ and alcohol metabolism.

Nutrient interactions to be aware of: very high-dose niacinamide may compete with NR via the salvage pathway, so avoid stacking both at therapeutic doses simultaneously. Tryptophan is an upstream NAD+ precursor via the de novo synthesis pathway; there's no negative interaction with NR, but both contribute to the same end pool.

Always consult your healthcare provider if you are taking prescription medications or managing a chronic health condition before adding NR supplementation.

Safety, Side Effects & Warnings

NR has one of the strongest safety profiles of any longevity supplement on the market, with GRAS status from the U.S. FDA and good tolerability in human trials up to 3,000mg/day.

• GRAS designation: Nicotinamide Riboside Chloride (NR-CL) holds GRAS status from the U.S. FDA (GRAS Notice 000635), confirming safety for use in food and dietary supplements.
• Well-tolerated in human trials up to 2,000mg/day: Multiple RCTs, including an 8–12 week trial in healthy overweight adults, found no significant difference in adverse events between NR and placebo groups, even at 2,000mg/day.
• Safe at 3,000mg/day in neurological disease: The NR-SAFE Parkinson's trial (2023, Nature Communications) confirmed safety at this very high dose with no serious adverse events.
• Common mild side effects (reported in a minority of users, typically at higher doses): mild nausea, loose stools, stomach discomfort, fatigue, or headache. These are generally transient and resolve with dose reduction or taking with food.

No flushing: Unlike nicotinic acid (niacin), NR does not cause the prostaglandin-mediated skin flushing that many people find uncomfortable, a significant tolerability advantage.

Who should consult a doctor before taking NR:

• Individuals with active cancer or undergoing chemotherapy
• Pregnant or breastfeeding women (insufficient safety data for these populations)
• Children (not studied)
• Individuals with known liver conditions (NAD+ metabolism is heavily liver-dependent)

Long-term safety: Human trials to date have been predominantly 8–24 weeks. NR has no known accumulation toxicity at recommended doses. Ongoing long-term safety studies (including the NADage Study, NCT06208527) are currently underway.

Deficiency & Who Is Most at Risk of Low NAD+

NAD+ isn't obtained from food in meaningful amounts, so low levels typically reflect accelerated depletion rather than inadequate dietary intake, and are most common in adults over 40, people with chronic inflammation, high alcohol intake, metabolic syndrome, poor sleep, high oxidative stress, or heavy training loads.

Who is most likely to have suboptimal NAD+ levels:

• Adults over 40: NAD+ decline begins in the 30s and accelerates significantly from the 40s onward, with some estimates of a 50% reduction by middle age
• People with high levels of chronic inflammation (which drives CD38 and PARP activity, consuming NAD+)
• Individuals with high alcohol intake (impairs NAD+ synthesis and increases consumption)
• People with metabolic syndrome, obesity, or type 2 diabetes (associated with chronically elevated PARP and inflammatory NAD+ consumption)
• Those with disrupted sleep or circadian rhythm (NAD+ synthesis is circadian-regulated)
• People with high levels of oxidative stress or DNA damage (drives PARP1 activation)
• Athletes with high training loads (mitochondrial demand and oxidative stress deplete NAD+ faster)

Signs that may indicate suboptimal NAD+ levels (not diagnostic, but associated in research):

• Persistent fatigue not explained by sleep or lifestyle
• Brain fog and reduced cognitive sharpness
• Reduced exercise tolerance and prolonged recovery
• Increased susceptibility to illness
• Accelerated skin aging

Frequently Asked Questions

What is nicotinamide riboside and what does it do?

NR is a form of vitamin B3 that the body converts into NAD+, a coenzyme essential for energy production, DNA repair, and the activation of longevity-related enzymes called sirtuins. Its primary role as a supplement is to restore the NAD+ levels that decline naturally with age.

How quickly does NR raise NAD+ levels?

Human trials show measurable increases in blood NAD+ within days of starting supplementation, with peak levels typically reached at 2–4 weeks of consistent daily use. The increase is cumulative, so consistency matters more than timing.

What's the difference between NR and NMN?

Both ultimately raise NAD+ levels. NR enters cells directly, while NMN must first be converted to NR before most cells can absorb it. NR currently has a larger base of published human clinical trials confirming its bioavailability and safety. Both are valid, but NR simply has more human evidence behind it.

Does NR cause the niacin flush?

No. The flushing associated with high-dose niacin (nicotinic acid) is caused by prostaglandin release via a specific receptor (GPR109A). NR does not activate this receptor and does not cause flushing, a key tolerability advantage.

Is NR safe to take with medications?

NR has no confirmed negative drug interactions in current clinical trial data. However, individuals taking chemotherapy, blood thinners, or managing liver conditions should consult their healthcare provider before adding NR.

Scientific References

1. Trammell SA, et al. "Nicotinamide riboside is uniquely and orally bioavailable in healthy humans." Nature Communications. 2016; 7:12948.
2. Martens CR, et al. "Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults." Nature Communications. 2018; 9:1286.
3. Zhang H, et al. "NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice." Science. 2016; 352(6292):1436–1443.
4. Elhassan YS, et al. "Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures." Cell Reports. 2019; 28(7):1717–1728.
5. Dollerup OL, et al. "A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects." American Journal of Clinical Nutrition. 2018; 108(2):343–353.
6. Brakedal B, et al. "The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease." Cell Metabolism. 2022; 35(3):501–511.
7. Tharakan R, et al. "NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease." Nature Communications. 2023; 14:7793.
8. Dolopikou CF, et al. "Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals." European Journal of Nutrition. 2020; 59:505–515.
9. Pilz PM, et al. "Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial." Nature Communications. 2024; 15:5023.
10. Hellmuth C, et al. "A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment." PMC. 2023; 10828186.
11. Nyambuya TM, et al. "Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial." eClinicalMedicine / The Lancet. 2025.
12. Xu W, et al. "Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation." Science Advances. 2024.
13. Conze D, Crespo-Barreto J, Kruger CL. "Safety assessment of nicotinamide riboside, a form of vitamin B3." Human & Experimental Toxicology. 2016; 35(10):1149–1160.
14. Covarrubias AJ, et al. "Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages." Nature Metabolism. 2020; 2:1265–1283.
15. Yang Y, Sauve AA. "NAD+ metabolism: Bioenergetics, signaling and manipulation for therapy." Biochimica et Biophysica Acta. 2016; 1864(12):1787–1800.

This article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It does not constitute medical advice and is independent of any specific product or brand. Always consult a qualified healthcare provider before beginning any new supplement regimen, particularly if you are pregnant, breastfeeding, taking medications, or managing a medical condition.